Systemic Inflammatory Response Syndrome (SIRS)
18
0
1
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
2 terminated out of 18 trials
83.3%
-3.2% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Myostatin and Irisin Levels in Predicting the Outcome of Patients With Systemic Inflammation: A Prospective Observational Study
Implementation of Timely Management of Sepsis and Septic Shock Protocol in the Emergency Department and Intensive Care Unit: A Quality Improvement Project at AFHJ
Effect of Lactiplantibacillus Plantarum DAD-13 on Inflammatory Markers in ICU Sepsis Patients
Oxygen Delivery During Cardiopulmonary Bypass And Inflammatory Reaction After Cardiac Surgery
Initial Feasibility Study of the CycloPE® Device
Optimization of Therapeutic Human Serum Albumin Infusion in Selected Critically Ill Patients
Lung and Systemic Inflammation in the Critically Ill Patient
Application of Stimulated Immune Response Change to Predict Outcome of Patient With Severe Sepsis
VENUS: Septic Gene Expression Using SeptiCyte
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
Genotypes and Phenotypes in Pediatric SIRS and Sepsis
The Analysis of Immuno-Nutrition Index in Advanced Gastric Cancer Receiving Preoperative Treatments
Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level
IMproved PREdiction of Severe Sepsis in the Emergency Department
Pharmacokinetic Study of Ceftaroline Fosamil/Avibactam in Adults With Augmented Renal Clearance
Electronic Application of a Severe Sepsis Screening Tool and Management Bundle
Systemic Inflammatory Response Syndrome (SIRS) in Patients Undergoing Major Procedures in Oral and Maxillofacial Surgery
Effects of Cardiopulmonary Bypass (CPB)-Leukocyte Filtration on Interleukins Serum Levels and Pulmonary Function